Post Graduate Degree in Chemistry (with at least 60 % marks) Or M.Pharm. (with at least 60 % marks) (Experience in Synthetic Organic Chemistry/Peptide Chemistry Related Project Work will be given preference).
MSc. / M.Tech Biotechnology, M.Pharm / MS (Pharm.) in Pharmaceutics / Pharmaceutical Biotechnology /Pharmacology / Pharmacognosy or allied disciplines with minimum 55% marks from a recognized university.
Centurion University’s School of Pharmacy and Life Sciences (SoPLS) is an institution established on 2016 dedicated to touch human lives in healthcare and happiness to ensure holistic societal development through skill based education, research, drug development and community welfare services, SoPLS committed to undertake the task of meeting professional and social needs like identification, cure, mitigation of disease and innovative drug design. It focuses in fulfiling student’s career in pharmaceutical sector, research and entrepreneurship.
Applications are invited for the position of Project Research Scientist-II (Non-Medical) in the ICMR funded project titled “A Randomized Trial of Enhanced Immunosuppression versus antifibrotic therapy and drug response prediction in progressive pulmonary fibrosis (RUNNER trial). (Project Code 1-1872) on temporary basis.
Post : Project Research Scientist-II I (Non- Medical)
PhD in chemistry or biological sciences or computational sciences. Hands on expertise and direct instrument operation & handling for mass spectrometry based analysis for metabolomics, metabolic flux, and quantitative proteomics.
Students having qualification with a minimum of 60% marks in B.Tech, M.Tech, M.Sc, in Life Sciences, Biochemistry, Biotechnology, Stem Cell Biology and Neurobiology / Neuroscience.
Macleods is one of the fastest growing pharmaceutical company, having strong presence in various therapeutics segments. Ranked amongst the top 10 companies.
Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally.